Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 14Gastrointestinal 10Gynecologic 8Thoracic 4Lymphoid 3Dermatologic 3Other 2Endocrine 2Other hematologic neoplasm 1Head & Neck 1Genitourinary 1CNS 1

Conditions

Neuroendocrine Tumors 394Multiple Endocrine Neoplasia Type 1 156Carcinoma, Neuroendocrine 123Thyroid Cancer, Papillary 118Pituitary Neoplasms 116Thyroid Neoplasms 100Pheochromocytoma 91Neoplasms 79Carcinoid Tumor 76Thyroid Carcinoma, Anaplastic 73Adrenocortical Carcinoma 73Paraganglioma 65Neoplasm Metastasis 56Adenocarcinoma, Follicular 53Carcinoma, Non-Small-Cell Lung 51Carcinoma, Medullary 50Insulinoma 49Pancreatic Neoplasms 47Adenoma, Islet Cell 47Colorectal Neoplasms 44Breast Neoplasms 44Small Cell Lung Carcinoma 42Sarcoma 42Gastro-enteropancreatic neuroendocrine tumor 42Carcinoma, Renal Cell 41Somatostatinoma 38Head and Neck Neoplasms 38Melanoma 37Lung Neoplasms 37Adrenal Gland Neoplasms 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Behavior × Endocrine × Clear all
NCT03781453 2020-04-08

POWERPLAY Phase 2: Development and Evaluation in Male-dominated Workplaces

University of British Columbia

Phase NA Completed
498 enrolled
Endocrine

Behavior, Health Behavior, Multiple Endocrine Neoplasia Type 1

NCT03548077 2019-10-08

POWERPLAY

University of British Columbia

Phase NA Completed
227 enrolled
Endocrine

Behavior, Neoplasms, Health Behavior, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡